Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Multidisciplinary molecular diagnostics: the 9th European meeting on molecular diagnostics.

Loonen AJ, Schuurman R, van den Brule AJ.

Expert Rev Mol Diagn. 2016;16(4):395-7. doi: 10.1586/14737159.2016.1152185.

PMID:
26854825
2.

Allelic imbalance at the HER2/TOP2A locus in breast cancer.

Huijsmans CJ, van den Brule AJ, Rigter H, Poodt J, van der Linden JC, Savelkoul PH, Hilbink M, Hermans MH.

Diagn Pathol. 2015 May 29;10:56. doi: 10.1186/s13000-015-0289-x.

3.

Correlation of haloperidol concentration in blood and cerebrospinal fluid: a pharmacokinetic study.

van Strien AM, Vermeulen Windsant-van den Tweel A, Leliveld-van den Heuvel M, di Biase M, van den Brule AJ, van Marum RJ.

J Clin Psychopharmacol. 2014 Aug;34(4):516-7. doi: 10.1097/JCP.0000000000000125. No abstract available.

PMID:
24875078
4.

Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit.

Loonen AJ, de Jager CP, Tosserams J, Kusters R, Hilbink M, Wever PC, van den Brule AJ.

PLoS One. 2014 Jan 27;9(1):e87315. doi: 10.1371/journal.pone.0087315.

5.

Comparison of pathogen DNA isolation methods from large volumes of whole blood to improve molecular diagnosis of bloodstream infections.

Loonen AJ, Bos MP, van Meerbergen B, Neerken S, Catsburg A, Dobbelaer I, Penterman R, Maertens G, van de Wiel P, Savelkoul P, van den Brule AJ.

PLoS One. 2013 Aug 15;8(8):e72349. doi: 10.1371/journal.pone.0072349.

6.

Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci.

Loonen AJ, Jansz AR, Bergland JN, Valkenburg M, Wolffs PF, van den Brule AJ.

J Clin Microbiol. 2012 Apr;50(4):1437-9. doi: 10.1128/JCM.06746-11.

7.

Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

Fariña Sarasqueta A, van Lijnschoten G, Lemmens VE, Rutten HJ, van den Brule AJ.

Mol Diagn Ther. 2011 Oct 1;15(5):277-83. doi: 10.2165/11592080-000000000-00000.

PMID:
21958378
8.

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.

Thunnissen E, Bovée JV, Bruinsma H, van den Brule AJ, Dinjens W, Heideman DA, Meulemans E, Nederlof P, van Noesel C, Prinsen CF, Scheidel K, van de Ven PM, de Weger R, Schuuring E, Ligtenberg M.

J Clin Pathol. 2011 Oct;64(10):884-92. doi: 10.1136/jclinpath-2011-200163.

PMID:
21947301
9.

TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients.

Fariña-Sarasqueta A, Gosens MJ, Moerland E, van Lijnschoten I, Lemmens VE, Slooter GD, Rutten HJ, van den Brule AJ.

Cell Oncol (Dordr). 2011 Aug;34(4):327-35. doi: 10.1007/s13402-011-0030-z.

PMID:
21630057
10.

SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics.

Fariña Sarasqueta A, Moerland E, de Bruyne H, de Graaf H, Vrancken T, van Lijnschoten G, van den Brule AJ.

J Mol Diagn. 2011 Mar;13(2):199-205. doi: 10.1016/j.jmoldx.2010.10.006.

11.

Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques.

Pierik A, Zwanenburg C, Moerland E, Broer D, Stapert H, van den Brule AJ.

J Clin Microbiol. 2011 Apr;49(4):1395-402. doi: 10.1128/JCM.01606-10.

12.

Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.

Fariña-Sarasqueta A, van Lijnschoten G, Rutten HJ, van den Brule AJ.

Cancer Chemother Pharmacol. 2010 Nov;66(6):1167-71. doi: 10.1007/s00280-010-1403-0.

PMID:
20665215
13.

Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis.

Krustrup D, Jensen HL, van den Brule AJ, Frisch M.

Int J Exp Pathol. 2009 Apr;90(2):182-9. doi: 10.1111/j.1365-2613.2008.00636.x.

14.

Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark.

Madsen BS, van den Brule AJ, Jensen HL, Wohlfahrt J, Frisch M.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2683-91. doi: 10.1158/1055-9965.EPI-08-0456.

15.

Risk factors for invasive squamous cell carcinoma of the vulva and vagina--population-based case-control study in Denmark.

Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M.

Int J Cancer. 2008 Jun 15;122(12):2827-34. doi: 10.1002/ijc.23446.

16.

Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma.

Gosens MJ, Klaassen RA, Tan-Go I, Rutten HJ, Martijn H, van den Brule AJ, Nieuwenhuijzen GA, van Krieken JH, Nagtegaal ID.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6617-23.

17.

Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.

de Heer P, Gosens MJ, de Bruin EC, Dekker-Ensink NG, Putter H, Marijnen CA, van den Brule AJ, van Krieken JH, Rutten HJ, Kuppen PJ, van de Velde CJ; Dutch Colorectal Cancer Group..

Clin Cancer Res. 2007 May 15;13(10):2955-60.

19.

The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women.

Tolstrup J, Munk C, Thomsen BL, Svare E, van den Brule AJ, Grønbaek M, Meijer C, Kjaer Krüger S.

Acta Obstet Gynecol Scand. 2006;85(9):1114-9.

PMID:
16929418
20.

HPV DNA detection and typing in cervical scrapes.

Snijders PJ, van den Brule AJ, Jacobs MV, Pol RP, Meijer CJ.

Methods Mol Med. 2005;119:101-14.

PMID:
16350400
21.

Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.

van Beek J, zur Hausen A, Snel SN, Berkhof J, Kranenbarg EK, van de Velde CJ, van den Brule AJ, Middeldorp JM, Meijer CJ, Bloemena E.

Am J Surg Pathol. 2006 Jan;30(1):59-65.

PMID:
16330943
22.

Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads.

Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, van den Brule AJ, Snijders PJ, Meijer CJ.

Clin Infect Dis. 2005 Sep 1;41(5):612-20.

PMID:
16080082
23.

Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers.

Kjaer SK, Munk C, Winther JF, Jørgensen HO, Meijer CJ, van den Brule AJ.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1528-33.

24.

The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study.

Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, Ronderos M, Muñoz N, van den Brule AJ.

J Infect Dis. 2005 Mar 15;191(6):907-16.

PMID:
15717266
25.

HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN.

Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Berkhof J, Hesselink AT, Lettink M, Starink TM, Stoof TJ, Snijders PJ, Meijer CJ.

Int J Cancer. 2005 Jan 1;113(1):36-41.

26.
27.

Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.

Smith JS, Bosetti C, Muñoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, Van Den Brule AJ, Franceschi S, Peeling RW; IARC multicentric case-control study..

Int J Cancer. 2004 Sep 1;111(3):431-9.

28.

Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Int J Epidemiol. 2004 Apr;33(2):416-25. Review.

PMID:
15082651
29.

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.

Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, v Groningen K, Boon ME, Keuning HJ, van Ballegooijen M, van den Brule AJ, Meijer CJ.

Int J Cancer. 2004 May 20;110(1):94-101.

30.

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.

Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ.

Cancer. 2004 Feb 25;102(1):11-8.

31.

EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.

van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E.

J Clin Oncol. 2004 Feb 15;22(4):664-70.

PMID:
14966089
32.

IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma.

zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morré SA, Meijer CJ, van den Brule AJ, Peña AS.

Int J Cancer. 2003 Dec 10;107(5):866-7. No abstract available.

33.

Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.

Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, Westenend PJ, Meijer CJ.

Int J Cancer. 2003 Dec 10;107(5):811-6.

34.

Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia.

Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Snijders PJ, Starink TM, Berkhof J, Meijer CJ.

Int J Cancer. 2003 Dec 10;107(5):804-10.

35.

In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.

van Beek J, Brink AA, Vervoort MB, van Zijp MJ, Meijer CJ, van den Brule AJ, Middeldorp JM.

J Gen Virol. 2003 Oct;84(Pt 10):2647-59.

PMID:
13679598
36.

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity.

Snijders PJ, van den Brule AJ, Meijer CJ.

J Pathol. 2003 Sep;201(1):1-6. Review.

PMID:
12950011
37.
38.

Pearly penile papules: still no reason for uneasiness.

Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, van Andel RE, Risse EK, Starink TM, Meijer CJ.

J Am Acad Dermatol. 2003 Jul;49(1):50-4.

PMID:
12833007
39.

No role for Epstein-Barr virus in Dutch hepatocellular carcinoma: a study at the DNA, RNA and protein levels.

zur Hausen A, van Beek J, Bloemena E, ten Kate FJ, Meijer CJ, van den Brule AJ.

J Gen Virol. 2003 Jul;84(Pt 7):1863-9.

PMID:
12810881
40.

Prevalence and persistence of asymptomatic Chlamydia trachomatis infections in urine specimens from Danish male military recruits.

van den Brule AJ, Munk C, Winther JF, Kjaer SK, Jørgensen HO, Meijer CJ, Morré SA.

Int J STD AIDS. 2002 Dec;13 Suppl 2:19-22.

PMID:
12537720
41.

The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.

Morré SA, van den Brule AJ, Rozendaal L, Boeke AJ, Voorhorst FJ, de Blok S, Meijer CJ.

Int J STD AIDS. 2002 Dec;13 Suppl 2:12-8.

PMID:
12537719
42.

Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders.

Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ.

Crit Rev Oncol Hematol. 2003 Jan;45(1):1-36. Review.

PMID:
12482570
43.

Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.

Smith JS, Herrero R, Bosetti C, Muñoz N, Bosch FX, Eluf-Neto J, Castellsagué X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group..

J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13.

PMID:
12419786
44.
45.

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.

Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ.

BMJ. 2002 Sep 14;325(7364):572.

46.

Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia.

Bleeker MC, Hogewoning CJ, Van Den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, Starink TM, Meijer CJ.

J Am Acad Dermatol. 2002 Sep;47(3):351-7.

PMID:
12196743
47.

A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas.

van Beek J, zur Hausen A, Kranenbarg EK, Warring RJ, Bloemena E, Craanen ME, van de Velde CJ, Middeldorp JM, Meijer CJ, van den Brule AJ.

Mod Pathol. 2002 Aug;15(8):870-7.

48.

Partner notification among asymptomatic Chlamydia trachomatis cases, by means of mailed specimens.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, van Eijk JT, Boeke AJ.

Br J Gen Pract. 2002 Aug;52(481):652-4.

49.

Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, van Eijk JT, Boeke AJ.

Br J Gen Pract. 2002 Aug;52(481):623-7.

50.

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

Stevens SJ, Verschuuren EA, Verkuujlen SA, Van Den Brule AJ, Meijer CJ, Middeldorp JM.

Leuk Lymphoma. 2002 Apr;43(4):831-40. Review.

PMID:
12153173
Items per page

Supplemental Content

Loading ...
Support Center